SPRY
NASDAQ · Biotechnology
Ars Pharmaceuticals Inc
$4.11
-0.04 (-0.96%)
Open$4.10
Previous Close$4.15
Day High$4.20
Day Low$4.10
52W High$13.15
52W Low$4.12
Volume—
Avg Volume1.58M
Market Cap408.73M
P/E Ratio—
EPS$-2.17
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,503.6% upside
Current
$4.11
$4.11
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 77.66M | 357.40M | 350.63M |
| Net Income | -157,850,977 | 35.24M | 44.72M |
| Profit Margin | -203.3% | 9.9% | 12.8% |
| EBITDA | -164,626,789 | 65.64M | 71.27M |
| Free Cash Flow | — | 46.75M | 30.69M |
| Rev Growth | +299.7% | +16.3% | -1.3% |
| Debt/Equity | 0.84 | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |